Search - tctmd.com

Displaying 1 - 20 of 26

Sort: Relevancy | Date

News Conference News ACC 2025

Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT

Caitlin E. Cox

March 29, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2024

Shelley Wood

December 03, 2024

News Daily News

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

L.A. McKeown

August 19, 2024

News Opinion CV Team Dispatch

August 2024 Dispatch for the CV Team

L.A. McKeown

August 01, 2024

News Opinion CV Team Dispatch

June 2024 Dispatch for the CV Team

L.A. McKeown

June 01, 2024

News Opinion CV Team Dispatch

May 2024 Dispatch for the CV Team

L.A. McKeown

May 01, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2024

Shelley Wood

February 01, 2024

News Daily News

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

Shelley Wood

January 17, 2024

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

News Conference News ESC 2023

ONCO DVT Supports 12 Months of Preventive DOACs in Cancer Patients

L.A. McKeown

August 30, 2023

News Daily News

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Michael O'Riordan

October 20, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2022

Shelley Wood

October 03, 2022

Presentation TCT 2022

Anticoagulation Strategies in High-Risk PE: Are DOACs Enough? When Do We Switch?

Presenter: Teresa Carman

September 19, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2022

Shelley Wood

September 01, 2022

News Opinion Editor's Corner ESC 2022

What’s Going to Be Hot at ESC 2022?

Shelley Wood

August 22, 2022

News Daily News

Risk of Repeat Stroke Underrecognized in Nonstenotic Carotid Lesions

L.A. McKeown

May 06, 2022

News Daily News

No Increased Bleeding With Alteplase in Stroke Patients on DOACs: Registry Data

Yael L. Maxwell

February 15, 2022

News Daily News

TCTMD’s Top 10 Most Popular Stories for October 2021

Shelley Wood

November 02, 2021

News Daily News

Rivaroxaban Again Linked to More Bleeding vs Other DOACs

Caitlin E. Cox

October 11, 2021

News Daily News

Long-term Anticoagulation After Unprovoked VTE: New Insights

Shelley Wood

September 13, 2021

Advertisement

Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT

TCTMD’s Top 10 Most Popular Stories for November 2024

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

August 2024 Dispatch for the CV Team

June 2024 Dispatch for the CV Team

May 2024 Dispatch for the CV Team

TCTMD’s Top 10 Most Popular Stories for January 2024

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

October 2023 News Roundup

ONCO DVT Supports 12 Months of Preventive DOACs in Cancer Patients

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

TCTMD’s Top 10 Most Popular Stories for September 2022

Anticoagulation Strategies in High-Risk PE: Are DOACs Enough? When Do We Switch?

TCTMD’s Top 10 Most Popular Stories for August 2022

What’s Going to Be Hot at ESC 2022?

Risk of Repeat Stroke Underrecognized in Nonstenotic Carotid Lesions

No Increased Bleeding With Alteplase in Stroke Patients on DOACs: Registry Data

TCTMD’s Top 10 Most Popular Stories for October 2021

Rivaroxaban Again Linked to More Bleeding vs Other DOACs

Long-term Anticoagulation After Unprovoked VTE: New Insights

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content